Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Hydrocephalus | Research article

Impaired consciousness and decreased glucose concentration of CSF as prognostic factors in immunocompetent patients with cryptococcal meningitis

Authors: Chen Zhang, Zheren Tan, Fafa Tian

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Cryptococcal meningitis (CM) is the most common fungal infection of the central nervous system and has high morbidity and mortality. Almost studies about prognostic factors have largely focused on the immunocompromised population rather than immunocompetent patients. So that we sought to conduct a retrospective study to determine prognostic factors which predict the outcomes in immunocompetent patients with CM.

Methods

We retrospectively collected and analyzed the demographic and clinical data of 76 apparently immunocompetent patients with cryptococcal meningitis from January 2003 to June 2019 in China. The clinical outcome was graded by the Glasgow outcome scale (GOS) at discharge, and patients were divided into good (score of 5) and unfavorable (score of 1–4) outcome groups, potential prognostic factors were analyzed.

Results

Non-parametric test confirmed that unfavorable outcome was associated with lower glucose level of CSF(P = 0.001), and Pearson’s χ2 analysis confirmed that unfavorable outcome was associated with opening pressure of CSF(>300mmH20, P = 0.038), impaired consciousness (P = 0.001), hydrocephalus(P = 0.045), and Shunt surgery (P = 0.045), and then multiple logistic regression analysis confirmed that impaired consciousness(P = 0.015) and lower glucose concentration of CSF(P = 0.012) increased the likelihood of unfavorable outcome in CM patients.

Conclusion

Impaired consciousness and decreased glucose concentration of CSF were independently prognostic factors which predict the unsatisfactory outcome in immunocompetent patients with CM.
Literature
2.
go back to reference Badali H, Alian S, Fakhim H, et al. Cryptococcal meningitis due to Cryptococcus neoformans genotype AFLP1/VNI in Iran: a review of the literature. Mycoses. 2015;58(12):689–93.CrossRef Badali H, Alian S, Fakhim H, et al. Cryptococcal meningitis due to Cryptococcus neoformans genotype AFLP1/VNI in Iran: a review of the literature. Mycoses. 2015;58(12):689–93.CrossRef
3.
go back to reference Agha Kuchak Afshari S, Shokohi T, Aghili R, et al. Epidemiology and molecular characterization of Cryptococcus neoformans isolated from pigeon excreta in Mazandaran province, northern Iran. J Mycol Med. 2012;22(2):160–6.CrossRef Agha Kuchak Afshari S, Shokohi T, Aghili R, et al. Epidemiology and molecular characterization of Cryptococcus neoformans isolated from pigeon excreta in Mazandaran province, northern Iran. J Mycol Med. 2012;22(2):160–6.CrossRef
4.
go back to reference Guo LY, Liu LL, Liu Y, et al. Characteristics and outcomes of cryptococcal meningitis in HIV seronegative children in Beijing, China, 2002–2013. BMC Infect Dis. 2016;16:635.CrossRef Guo LY, Liu LL, Liu Y, et al. Characteristics and outcomes of cryptococcal meningitis in HIV seronegative children in Beijing, China, 2002–2013. BMC Infect Dis. 2016;16:635.CrossRef
5.
go back to reference Chen CH, Sy HN, Lin LJ, et al. Epidemiological characterization and prognostic factors in patients with confirmed cerebral cryptococcosis in Central Taiwan. J Venom Anim Toxins Incl Trop Dis. 2015;21:12.CrossRef Chen CH, Sy HN, Lin LJ, et al. Epidemiological characterization and prognostic factors in patients with confirmed cerebral cryptococcosis in Central Taiwan. J Venom Anim Toxins Incl Trop Dis. 2015;21:12.CrossRef
7.
go back to reference Li M, Chen Z, Xu L, et al. A comparison of the clinical characteristics and outcomes of Cryptococcal meningitis in HIV-negative individuals with and without immunosuppression. Neurologist. 2019;24(1):1–5.CrossRef Li M, Chen Z, Xu L, et al. A comparison of the clinical characteristics and outcomes of Cryptococcal meningitis in HIV-negative individuals with and without immunosuppression. Neurologist. 2019;24(1):1–5.CrossRef
8.
go back to reference Ecevit IZ, Clancy CJ, Schmalfuss IM, et al. The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy. Clin Infect Dis. 2006;42:1443–7.CrossRef Ecevit IZ, Clancy CJ, Schmalfuss IM, et al. The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy. Clin Infect Dis. 2006;42:1443–7.CrossRef
9.
go back to reference Lui G, Lee N, Ip M, et al. Cryptococcosis in apparently immunocompetent patients. QJM. 2006;99:143–51.CrossRef Lui G, Lee N, Ip M, et al. Cryptococcosis in apparently immunocompetent patients. QJM. 2006;99:143–51.CrossRef
10.
go back to reference Lagrou K, van Eldere J, Keuleers S, et al. Zoonotic transmission of Cryptococcus neoformans from a magpie to an immunocompetent patient. J Intern Med. 2005;257:385–8.CrossRef Lagrou K, van Eldere J, Keuleers S, et al. Zoonotic transmission of Cryptococcus neoformans from a magpie to an immunocompetent patient. J Intern Med. 2005;257:385–8.CrossRef
11.
go back to reference Nosanchuk JD, Shoham S, Fries BC, et al. Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient. Ann Intern Med. 2000;132:205–8.CrossRef Nosanchuk JD, Shoham S, Fries BC, et al. Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient. Ann Intern Med. 2000;132:205–8.CrossRef
12.
go back to reference Sonneville R, Magalhaes E, Meyfroidt G. Central nervous system infections in immunocompromised patients. Curr Opin Crit Care. 2017;23(2):128–33.CrossRef Sonneville R, Magalhaes E, Meyfroidt G. Central nervous system infections in immunocompromised patients. Curr Opin Crit Care. 2017;23(2):128–33.CrossRef
13.
go back to reference Henao-Martínez AF, Chastain DB, Franco-Paredes C. Treatment of cryptococcosis in non-HIV immunocompromised patients. Curr Opin Infect Dis. 2018;31(4):278–85.CrossRef Henao-Martínez AF, Chastain DB, Franco-Paredes C. Treatment of cryptococcosis in non-HIV immunocompromised patients. Curr Opin Infect Dis. 2018;31(4):278–85.CrossRef
14.
go back to reference Yuchong C, Fubin C, Jianghan C, et al. Cryptococcosis in China (1985-2010): review of cases from Chinese database. Mycopathologia. 2012;173(5–6):329–35.CrossRef Yuchong C, Fubin C, Jianghan C, et al. Cryptococcosis in China (1985-2010): review of cases from Chinese database. Mycopathologia. 2012;173(5–6):329–35.CrossRef
15.
go back to reference Lu CH, Chang HW, Chuang YC. The prognostic factors of cryptococcal meningitis in HIV-negative patients. J Hospital Infect. 1999;42:313–20.CrossRef Lu CH, Chang HW, Chuang YC. The prognostic factors of cryptococcal meningitis in HIV-negative patients. J Hospital Infect. 1999;42:313–20.CrossRef
16.
go back to reference Shih CC, Chen YC, Chang SC, et al. Cryptococcal meningitis in non-HIV-infected patients. QJM. 2000;93:245–51.CrossRef Shih CC, Chen YC, Chang SC, et al. Cryptococcal meningitis in non-HIV-infected patients. QJM. 2000;93:245–51.CrossRef
17.
go back to reference Wu MH, Xu ZY, Weng XH, et al. A clinical analysis of 74 cases of cryptococcosis. Acta Academiae Med Shanghai. 1987;14:457–9. Wu MH, Xu ZY, Weng XH, et al. A clinical analysis of 74 cases of cryptococcosis. Acta Academiae Med Shanghai. 1987;14:457–9.
18.
go back to reference Yao Z, Liao W, Chen R. Management of cryptococcosis in non HIV-related patients. Med Mycol. 2005;43:245–51.CrossRef Yao Z, Liao W, Chen R. Management of cryptococcosis in non HIV-related patients. Med Mycol. 2005;43:245–51.CrossRef
19.
go back to reference Zhu LP, Wu JQ, Xu B, et al. Cryptococcal meningitis in non-HIV-infected patients in a Chinese tertiary care hospital, 1997–2007. Med Mycol. 2010;48:570–9.CrossRef Zhu LP, Wu JQ, Xu B, et al. Cryptococcal meningitis in non-HIV-infected patients in a Chinese tertiary care hospital, 1997–2007. Med Mycol. 2010;48:570–9.CrossRef
20.
go back to reference Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis. 2000;30:710–8.CrossRef Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis. 2000;30:710–8.CrossRef
21.
go back to reference Vidal JE, Gerhardt J, Peixoto de Miranda EJ, et al. Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort. Diagn Microbiol Infect Dis. 2012;73:68–73.CrossRef Vidal JE, Gerhardt J, Peixoto de Miranda EJ, et al. Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort. Diagn Microbiol Infect Dis. 2012;73:68–73.CrossRef
22.
go back to reference Liliang PC, Liang CL, Chang WN, et al. Shunt surgery for hydrocephalus complicating cryptococcal meningitis in human immunodeficiency virus-negative patients. Clin Infect Dis. 2003;37:673–8.CrossRef Liliang PC, Liang CL, Chang WN, et al. Shunt surgery for hydrocephalus complicating cryptococcal meningitis in human immunodeficiency virus-negative patients. Clin Infect Dis. 2003;37:673–8.CrossRef
23.
go back to reference Hung CW, Chang WN, Kung CT, et al. Predictors and long-term outcome of seizures in human immuno-deficiency virus (HIV)-negative cryptococcal meningitis. BMC Neurol. 2014;14:208.CrossRef Hung CW, Chang WN, Kung CT, et al. Predictors and long-term outcome of seizures in human immuno-deficiency virus (HIV)-negative cryptococcal meningitis. BMC Neurol. 2014;14:208.CrossRef
24.
go back to reference Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID mycoses study group and the AIDS Clinical Trials Group. N Engl J Med. 1992;326(2):83–9.CrossRef Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID mycoses study group and the AIDS Clinical Trials Group. N Engl J Med. 1992;326(2):83–9.CrossRef
25.
go back to reference Liu Y, Jiang Y, Wu A, et al. Prognostic significance of serum antioxidant parameters in immunocompetent patients with cryptococcal meningitis. Eur J Clin Microbiol Infect Dis. 2012;31(9):2359–67.CrossRef Liu Y, Jiang Y, Wu A, et al. Prognostic significance of serum antioxidant parameters in immunocompetent patients with cryptococcal meningitis. Eur J Clin Microbiol Infect Dis. 2012;31(9):2359–67.CrossRef
26.
go back to reference Welch H, Hasbun R. Lumbar puncture and cerebrospinal fluid analysis. In: Aminoff M, Boller F, Swaab D, editors. editors Handbook of clinical neurology; 2010. p. 31–49. Welch H, Hasbun R. Lumbar puncture and cerebrospinal fluid analysis. In: Aminoff M, Boller F, Swaab D, editors. editors Handbook of clinical neurology; 2010. p. 31–49.
27.
go back to reference Cao W, Jian C, Zhang H, et al. Comparison of clinical features and prognostic factors of Cryptococcal meningitis caused by Cryptococcus neoformans in patients with and without pulmonary nodules. Mycopathologia. 2019;184(1):73–80.CrossRef Cao W, Jian C, Zhang H, et al. Comparison of clinical features and prognostic factors of Cryptococcal meningitis caused by Cryptococcus neoformans in patients with and without pulmonary nodules. Mycopathologia. 2019;184(1):73–80.CrossRef
28.
go back to reference Severien C, Jacobs KH, Schoenemann W. Marked pleocytosis and hypoglycorrhachia in coxsackie meningitis. Pediatr Infect Dis. 1994;13:322–3.CrossRef Severien C, Jacobs KH, Schoenemann W. Marked pleocytosis and hypoglycorrhachia in coxsackie meningitis. Pediatr Infect Dis. 1994;13:322–3.CrossRef
29.
go back to reference Dzupova O, Rozsypal H, Prochazka B, et al. Acute bacterial meningitis in adults: predictors of outcome. Scand J Infect Dis. 2009;41:348–54.CrossRef Dzupova O, Rozsypal H, Prochazka B, et al. Acute bacterial meningitis in adults: predictors of outcome. Scand J Infect Dis. 2009;41:348–54.CrossRef
30.
go back to reference Singh N, Lortholary O, Dromer F, et al. Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings. Transplantation. 2008;86(5):647–51.CrossRef Singh N, Lortholary O, Dromer F, et al. Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings. Transplantation. 2008;86(5):647–51.CrossRef
31.
go back to reference Lee SC, Dickson DW, Casadevall A. Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. Hum Pathol. 1996;27:839–47.CrossRef Lee SC, Dickson DW, Casadevall A. Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. Hum Pathol. 1996;27:839–47.CrossRef
32.
go back to reference Kwee RM, Kwee TC. Virchow-Robin spaces at MR imaging. Radiographies. 2007;27:1071–86.CrossRef Kwee RM, Kwee TC. Virchow-Robin spaces at MR imaging. Radiographies. 2007;27:1071–86.CrossRef
33.
go back to reference Tan ZR, Long XY, Li GL, et al. Spectrum of neuroimaging findings in cryptococcal meningitis in immunocompetent patients in China - a series of 18 cases. J Neurol Sci. 2016;368:132–7.CrossRef Tan ZR, Long XY, Li GL, et al. Spectrum of neuroimaging findings in cryptococcal meningitis in immunocompetent patients in China - a series of 18 cases. J Neurol Sci. 2016;368:132–7.CrossRef
34.
go back to reference Liao CH, Chi CY, Wang YJ, et al. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis. J Microbiol Immunol Infect. 2012;45(4):296–304.CrossRef Liao CH, Chi CY, Wang YJ, et al. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis. J Microbiol Immunol Infect. 2012;45(4):296–304.CrossRef
35.
go back to reference Qu J, Zhou T, Zhong C, et al. Comparison of clinical features and prognostic factors in HIV-negative adults with cryptococcal meningitis and tuberculous meningitis: a retrospective study. BMC Infect Dis. 2017;17(1):51.CrossRef Qu J, Zhou T, Zhong C, et al. Comparison of clinical features and prognostic factors in HIV-negative adults with cryptococcal meningitis and tuberculous meningitis: a retrospective study. BMC Infect Dis. 2017;17(1):51.CrossRef
Metadata
Title
Impaired consciousness and decreased glucose concentration of CSF as prognostic factors in immunocompetent patients with cryptococcal meningitis
Authors
Chen Zhang
Zheren Tan
Fafa Tian
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-4794-5

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.